249 related articles for article (PubMed ID: 26982954)
21. Liver transplantation using organs from deceased organ donors: a single organ transplant center experience.
Han M; Guo ZY; Zhao Q; Wang XP; Yuan XP; Jiao XY; Yang CH; Wang DP; Ju WQ; Wu LW; Hu AB; Tai Q; Ma Y; Zhu XF; He XS
Hepatobiliary Pancreat Dis Int; 2014 Aug; 13(4):409-15. PubMed ID: 25100126
[TBL] [Abstract][Full Text] [Related]
22. Living donor liver transplantation for hepatocellular carcinoma.
Isik B; Ince V; Karabulut K; Kayaalp C; Yilmaz S
Transplant Proc; 2012; 44(6):1713-6. PubMed ID: 22841251
[TBL] [Abstract][Full Text] [Related]
23. Prognostic role of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma undergoing liver transplantation.
Zhang W; Kim R; Quintini C; Hashimoto K; Fujiki M; Diago T; Eghtesad B; Miller C; Fung J; Tan A; Menon KV; Aucejo F
Liver Transpl; 2015 Jan; 21(1):101-11. PubMed ID: 25283528
[TBL] [Abstract][Full Text] [Related]
24. Effects of loco regional treatments before living donor liver transplantation on overall survival and recurrence-free survival in South Korean patients with hepatocellular carcinoma.
Na GH; Kim EY; Hong TH; You YK; Kim DG
HPB (Oxford); 2016 Jan; 18(1):98-106. PubMed ID: 26776857
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.
Kim JM; Kwon CH; Joh JW; Choi MS; Lee JH; Koh KC; Paik SW; Kim GS; Kim SJ; Lee SK; Yoo BC
Transplant Proc; 2012 Mar; 44(2):403-8. PubMed ID: 22410028
[TBL] [Abstract][Full Text] [Related]
26. Risk factors of microvascular invasion, portal vein tumor thrombosis and poor post-resectional survival in HBV-related hepatocellular carcinoma.
Zhou L; Rui JA; Wang SB; Chen SG; Qu Q
Hepatogastroenterology; 2014 Sep; 61(134):1696-703. PubMed ID: 25436365
[TBL] [Abstract][Full Text] [Related]
27. Donation After Circulatory Death Is Associated With Similar Posttransplant Survival in All but the Highest-Risk Hepatocellular Carcinoma Patients.
Silverstein J; Roll G; Dodge JL; Grab JD; Yao FY; Mehta N
Liver Transpl; 2020 Sep; 26(9):1100-1111. PubMed ID: 32531867
[TBL] [Abstract][Full Text] [Related]
28. Hepatocyte nuclear factor 1β is a novel prognostic marker independent of the Milan criteria in transplantable hepatocellular carcinoma: a retrospective analysis based on tissue microarrays.
Shim JH; Lee HC; Han S; Kang HJ; Yu E; Lee SG
Liver Transpl; 2013 Mar; 19(3):336-45. PubMed ID: 23203386
[TBL] [Abstract][Full Text] [Related]
29. Complete pathologic response to pretransplant locoregional therapy for hepatocellular carcinoma defines cancer cure after liver transplantation: analysis of 501 consecutively treated patients.
Agopian VG; Morshedi MM; McWilliams J; Harlander-Locke MP; Markovic D; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Hiatt JR; Busuttil RW
Ann Surg; 2015 Sep; 262(3):536-45; discussion 543-5. PubMed ID: 26258323
[TBL] [Abstract][Full Text] [Related]
30. Use of Elderly Allografts in Liver Transplantation.
Paterno F; Wima K; Hoehn RS; Cuffy MC; Diwan TS; Woodle SE; Abbott DE; Shah SA
Transplantation; 2016 Jan; 100(1):153-8. PubMed ID: 26154390
[TBL] [Abstract][Full Text] [Related]
31. Outcomes of liver transplantation for hepatocellular carcinoma in donation after circulatory death compared with donation after brain death: A systematic review and meta-analysis.
Al-Ameri AAM; Zheng S
Ann Hepatol; 2024; 29(3):101484. PubMed ID: 38417629
[TBL] [Abstract][Full Text] [Related]
32. Imaging surveillance and multidisciplinary review improves curative therapy access and survival in HCC patients.
Gaba RC; Kallwitz ER; Parvinian A; Bui JT; Von Roenn NM; Berkes JL; Cotler SJ
Ann Hepatol; 2013; 12(5):766-73. PubMed ID: 24018494
[TBL] [Abstract][Full Text] [Related]
33. Liver transplantation for T3 lesions has higher waiting list mortality but similar survival compared to T1 and T2 lesions.
Schmitt TM; Kumer SC; Shah N; Argo CK; Northup PG
Ann Hepatol; 2010; 9(4):390-6. PubMed ID: 21057157
[TBL] [Abstract][Full Text] [Related]
34. Primary versus salvage living donor liver transplantation for patients with hepatocellular carcinoma: impact of microvascular invasion on survival.
Moon JI; Kwon CH; Joh JW; Choi GS; Jung GO; Kim JM; Shin M; Choi SJ; Kim SJ; Lee SK
Transplant Proc; 2012 Mar; 44(2):487-93. PubMed ID: 22410053
[TBL] [Abstract][Full Text] [Related]
35. Serum C-reactive protein is a useful biomarker for predicting outcomes after liver transplantation in patients with hepatocellular carcinoma.
An HJ; Jang JW; Bae SH; Choi JY; Yoon SK; Lee MA; You YK; Kim DG; Jung ES
Liver Transpl; 2012 Dec; 18(12):1406-14. PubMed ID: 22821639
[TBL] [Abstract][Full Text] [Related]
36. Waiting time predicts survival after liver transplantation for hepatocellular carcinoma: a cohort study using the United Network for Organ Sharing registry.
Schlansky B; Chen Y; Scott DL; Austin D; Naugler WE
Liver Transpl; 2014 Sep; 20(9):1045-56. PubMed ID: 24838471
[TBL] [Abstract][Full Text] [Related]
37. Impact of model for end-stage liver disease score on long-term survival following liver transplantation for hepatocellular carcinoma.
Roma J; Balbi E; Pacheco-Moreira L; Zyngier I; Araujo A; Agoglia L; Steinbruck K; Velaverde LG; Martinho JM
Transplant Proc; 2012 Oct; 44(8):2423-7. PubMed ID: 23026611
[TBL] [Abstract][Full Text] [Related]
38. Diabetes mellitus may affect the long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after liver transplantation.
Zhang Q; Deng YL; Liu C; Huang LH; Shang L; Chen XG; Wang LT; Du JZ; Wang Y; Wang PX; Zhang H; Shen ZY
World J Gastroenterol; 2016 Nov; 22(43):9571-9585. PubMed ID: 27920478
[TBL] [Abstract][Full Text] [Related]
39. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio.
Harimoto N; Shirabe K; Nakagawara H; Toshima T; Yamashita Y; Ikegami T; Yoshizumi T; Soejima Y; Ikeda T; Maehara Y
Transplantation; 2013 Dec; 96(11):1008-12. PubMed ID: 24113512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]